# The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus

Study · id `cardio:ct-nct02418884` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02418884](<https://clinicaltrials.gov/study/NCT02418884>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02418884

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 122 participants.

## Technical summary

Registry record NCT02418884. Allocation not applicable; no masking; primary purpose prevention. Start 2015-04 (registry gives no type); primary completion 2018-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 122 participants (planned count; ClinicalTrials.gov record NCT02418884, source copy `cardio:ctgov-nct02418884-2015-04-16`, retrieved 2026-10-26)
- Start date: 2015-04 (registry gives no type) (ClinicalTrials.gov record NCT02418884, source copy `cardio:ctgov-nct02418884-2015-04-16`, retrieved 2026-10-26)
- Primary completion: 2018-03 (anticipated) (ClinicalTrials.gov record NCT02418884, source copy `cardio:ctgov-nct02418884-2015-04-16`, retrieved 2026-10-26)
- Completion: 2018-03 (anticipated) (ClinicalTrials.gov record NCT02418884, source copy `cardio:ctgov-nct02418884-2015-04-16`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02418884-2015-04-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus
- Condition: Coronary Artery Disease
- Intervention (Drug): rosuvastatin
- Lead sponsor: Sir Run Run Shaw Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Sir Run Run Shaw Hospital (`cardio:org-sir-run-run-shaw-hospital`)

## Provenance

Content hash: 26476cd571b72ede2dc2ac6bb0aa61f6b4d775d430509dce12c23584cf51fad9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
